American Portfolios Advisors’s Sutro Biopharma STRO Stock Holding History

American Portfolios Advisors’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$55.5K	Hold	1,000	–	–	﹤0.01%	1637
2022 Q2	$52.1K	Buy	1,000 +90	+10%	+$5.03K	﹤0.01%	1735
2022 Q1	$74.8K	Buy	910 +107	+13%	+$10.2K	﹤0.01%	1685
2021 Q4	$119K	Hold	803	–	–	﹤0.01%	1429
2021 Q3	$152K	Hold	803	–	–	0.01%	1259
2021 Q2	$149K	Buy	803 +38	+5%	+$7.44K	0.01%	1244
2021 Q1	$174K	Buy	765 +25	+3%	+$5.93K	0.01%	1087
2020 Q4	$161K	Sell	740 -108	-13%	-$17.9K	0.01%	973
2020 Q3	$85.2K	Buy	848 +250	+42%	+$23.6K	﹤0.01%	1123
2020 Q2	$46.4K	Buy	598 +250	+72%	+$24K	﹤0.01%	1315
2020 Q1	$35.4K	Buy	348 +130	+60%	+$13.7K	﹤0.01%	1314
2019 Q4	$23.9K	Buy	218 +158	+263%	+$16.3K	﹤0.01%	1655
2019 Q3	$5.45K	Buy	+60	New	+$6.06K	﹤0.01%	2168

Other funds holding STRO

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

American Portfolios Advisors's STRO Position: Q3 2022 in Review

American Portfolios Advisors held its Sutro Biopharma (STRO) position steady in Q3 2022 at 1,000 shares worth $55.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1637.

American Portfolios Advisors first reported a position in STRO in Q3 2019 and has held it in 13 quarters since. The position peaked at $174K in Q1 2021. 113 funds tracked by Wall St. Rank hold STRO as of Q3 2022.

American Portfolios Advisors held 1,000 shares of Sutro Biopharma worth $55.5K as of Q3 2022.
American Portfolios Advisors left its Sutro Biopharma share count unchanged in Q3 2022.
Sutro Biopharma made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1637 holding.
American Portfolios Advisors first reported a position in Sutro Biopharma in Q3 2019 and has held it in 13 quarters since.
American Portfolios Advisors's Sutro Biopharma position peaked at $174K in Q1 2021.
113 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.